Joao Filipe Raposo
Overview
Explore the profile of Joao Filipe Raposo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
271
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hoffmann L, Kohls M, Arnolds S, Achenbach P, Bergholdt R, Bonifacio E, et al.
BMJ Open
. 2025 Jan;
15(1):e088522.
PMID: 39753267
Introduction: The identification of type 1 diabetes at an early presymptomatic stage has clinical benefits. These include a reduced risk of diabetic ketoacidosis (DKA) at the clinical manifestation of the...
2.
do Rosario F, Soares M, Mesquita F, Raposo J
Diabetol Int
. 2024 Aug;
15(3):550-561.
PMID: 39101166
Objective: Hypoglycemia constitutes a communication barrier between youth with type 1 diabetes, their family members and health professionals. A narrative tool may contribute to a more effective communication. Methods: Semi-structured...
3.
Bertoluci M, Silva Junior W, Valente F, Araujo L, Lyra R, Jacome de Castro J, et al.
Diabetol Metab Syndr
. 2023 Jul;
15(1):160.
PMID: 37468901
Background: The management of antidiabetic therapy in people with type 2 diabetes (T2D) has evolved beyond glycemic control. In this context, Brazil and Portugal defined a joint panel of four...
4.
Heller S, Raposo J, Tofe S, Hanif W, Schroner Z, Down S, et al.
Clin Diabetes
. 2023 Apr;
41(2):154-162.
PMID: 37092154
Despite increases in the availability and effectiveness of other therapies, insulin remains an essential treatment for approximately 30 million people with type 2 diabetes worldwide. The development of biosimilars has...
5.
Coelho M, Patarrao R, Sousa-Lima I, Ribeiro R, Meneses M, Andrade R, et al.
Nutrients
. 2023 Jan;
15(1).
PMID: 36615664
Coffee may protect against non-alcoholic fatty liver disease (NAFLD), but the roles of the caffeine and non-caffeine components are unclear. Coffee intake by 156 overweight subjects (87% with Type-2-Diabetes, T2D)...
6.
Meneses M, Patarrao R, Pinheiro T, Coelho I, Carrico N, Marques A, et al.
Eur J Clin Invest
. 2022 Dec;
53(4):e13934.
PMID: 36479853
Background: Diabetes is a heterogeneous and multifactorial disease. However, glycemia and glycated hemoglobin have been the focus of diabetes diagnosis and management for the last decades. As diabetes management goes...
7.
Silva-Nunes J, Nascimento E, Louro J, Dores J, Laginha T, Goncalves-Ferreira A, et al.
Metabolites
. 2022 Nov;
12(11).
PMID: 36422260
Liraglutide is a long-acting glucagon-like peptide-1 receptor agonist prescribed to diabetic patients for glycaemic control. To understand the impact of liraglutide in the real-world setting, this study analysed its effects...
8.
Do O D, Serrabulho L, Ribeiro R, Silva S, Covinhas A, Afonso M, et al.
Acta Med Port
. 2022 Mar;
35(10):729-737.
PMID: 35239472
Introduction: The increasing burden of diabetes poses a great challenge to healthcare systems and economy worldwide. Although modern therapeutic strategies for diabetes are widely available, most patients still fail to...
9.
Matos C, van Hunsel F, Tavares Ribeiro R, Do O D, Raposo J
Ther Adv Drug Saf
. 2022 Feb;
11:2042098620953935.
PMID: 35173953
Objective: The aim was to assess the perception of risk for developing adverse drug reaction (ADRs) and knowledge, attitudes and opinions regarding pharmacovigilance in diabetic patients, and to investigate the...
10.
Al-Musawe L, Torre C, Guerreiro J, Rodrigues A, Raposo J, Mota-Filipe H, et al.
Int J Clin Pract
. 2021 Sep;
75(11):e14847.
PMID: 34516684
Aims: In older adults with type 2 diabetes (T2D), overtreatment remains prevalent and undertreatment ignored. The main objective is to estimate the prevalence and examine factors associated with potential overtreatment...